EP0918862A2 - Transduction de signal de proteine g dans des plantes - Google Patents

Transduction de signal de proteine g dans des plantes

Info

Publication number
EP0918862A2
EP0918862A2 EP97929402A EP97929402A EP0918862A2 EP 0918862 A2 EP0918862 A2 EP 0918862A2 EP 97929402 A EP97929402 A EP 97929402A EP 97929402 A EP97929402 A EP 97929402A EP 0918862 A2 EP0918862 A2 EP 0918862A2
Authority
EP
European Patent Office
Prior art keywords
protein
plants
dna
sequence
coupled receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97929402A
Other languages
German (de)
English (en)
Inventor
Richard Hooley
Stella Plakidou-Dymock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bristol
Original Assignee
University of Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613617.1A external-priority patent/GB9613617D0/en
Priority claimed from GBGB9706118.8A external-priority patent/GB9706118D0/en
Application filed by University of Bristol filed Critical University of Bristol
Publication of EP0918862A2 publication Critical patent/EP0918862A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8291—Hormone-influenced development
    • C12N15/8295—Cytokinins

Definitions

  • This invention relates to the application of recombinant DNA technology to plants, specifically, to the discovery, isolation and cloning of a G protein-coupled receptor homologue for mediating both G protein signal transduction pathways and G protein- independent signal transduction pathways in plants.
  • G protein-coupled receptors constitute a large and functionally diverse superfamily of integral membrane proteins involved in the transduction of signals across cell membranes.
  • the G-protein signalling pathway is also one of the most highly conserved mechanisms for transducing extracellular signals.
  • the GPCRs are an essential element of this pathway, although to date, they have not been isolated from plants.
  • Tnese signals include olfactrants, biogenic amines, vertebrate and invertebrate visual pigments, neuropeptides, a range of autocrine, paracrine and endocrine factors, insect pheromones, fungal mating factors and chemotactic substances.
  • these receptors share considerable structural homology, reflecting their common mechanism of action.
  • the DNA and deduced protein sequence of more than 700 GPCRs are known with all sharing a common feature of 7 stretches of hydrophobic amino acids each capable of forming a transmembrane ⁇ -helix.
  • GPCRs are typically thought to traverse the membrane 7 times, forming a helical cluster with associated extracellular and intracellular loops. This hypothesis is supported by a number of molecular modelling studies (Strader et al . , Ann . Revi ew of Bioche . 63:101-132 (1994)). GPCRs may be classified into families on the basis of primary sequence homology in the transmembrane domains . In general, these homologies are greatest for species nomologues (85-90% identity) , and sub-types of the same receptor (60-80% identity) . Members of the same family can show as low as 35-40% identity and unrelated GPCRs may be only 20-25% identical in the transmembrane domains.
  • GPCRs have been identified in vertebrates, invertebrates, arthropods, insects, nematodes, fungi, yeast, and viruses, but never in plants.
  • C. reinhardtii a green algae
  • GPCRs In signal transduction, ligand binding occurs through a variety of mechanisms, depending on the class of ligand.
  • the cavity formed by the cluster of transmembrane helices appears to be involved in binding ligands such as adrenaline, serotonin and acetylcholine .
  • Some of the peptide receptors bind ligands through the exofacial regions of the extracellular loops.
  • Other GPCRs appear to use long N-terminal extracellular domains in a variety of ways to both bind and orientate the ligand with respect to the extracellular face and transmembrane regions of the receptor. It is believed that GPCRs signal through heterotrimeric GTP-binding proteins (G proteins) which comprise a , ⁇ and ⁇ subunits.
  • G proteins heterotrimeric GTP-binding proteins
  • G proteins There are far fewer classes of G proteins than GPCRs, probably no more than a dozen in vertebrates. This suggests that different classes of GPCRs signal through a single class of G protein. Thus, receptors determine the specificity of the response, and the G proteins are "multifunctional" signalling molecules. Therefore, in order to specifically manipulate G protein signal transduction, attention must be focused on the G protein- coupled receptors and their ligands.
  • GPCRs in plants will function similarly to their vertebrate and invertebrate counterparts, for instance, in responding to fungal elicitor ⁇ , light, responding to plant hormones, as well as regulating cell division and differentiation.
  • the use of such plant GPCRs would be of great benefit to plant breeders .
  • sensitivity, activity or sepcificity might allow plant growers to manipulate plant responses to both light quality and quantity and thus, alter the transition from vegetative to reproductive growth- -hence delaying or advancing flowering. It may also be possible o influence the sensitivity to UN/blue light which may have important long term implications in relation to ozone layer depletion in the atmosphere.
  • G protein-coupled receptors in plants, the agricultural and horticultural industries would have the ability to manipulate responses to plant hormones by altering G protein signal transduction and likely affect events such as: seed dormancy, germination, elongation growth, responses to stress, flower initiation and development, and fruit ripening and development. Further, by, for example, altering GPCR expression, sensitivity, activity or specificity, it could be possible to manipulate ion/nutrient transport, disease resistance and response to pathogens as well as cellular division and differentiation. Other signals in plants possibly involving G proteins are hormones such as auxin, gibberellin and abscisic acid, as well as fungal elicitors.
  • the present invention is based on the first ever isolation of a G protein-coupled receptor homologue in plants. Specifically, this invention relates to the isolation of a novel and useful gene to a plant G protein- coupled receptor homologue from the family Cruciferae and relates to methods of isolation, genetic constructs and transgenic plants containing this gene .
  • nucleic acid and amino acid sequences encoding a G protein- coupled receptor homologue encoding a G protein- coupled receptor homologue.
  • This novel GPCR homologue gene referred herein as AtGCRl , was isolated from the plant Arabidopsis thaliana .
  • the DNA and amino acid sequences of Fig. 1 and Fig 2 and sequences substantially homologous to the sequences of Fig 1 and Fig. 2 (i.e. also encoding a plant G protein-coupled receptor homologue) are claimed by way of this invention.
  • the nucleotide and amino acid sequences forming part of this invention may in principle, be isolated from any fungi or plant .
  • the plant G protein-coupled receptor homologue of Fig 1 and Fig. 2 influences sensitivity to cytokinins in plants, specifically in Arabidopsis .
  • Cytokinins are purine derivatives and are a profoundly important class of plant hormones and are known to influence cell division, differentiation, senescence, responses to light, flowering and apical dominance (See: Plan t Growth
  • a preferred aspect of this invention is, therefore, a DNA sequence or a fragment of a DNA sequence encoding a GPCR homologue isolated from fungi or plants, preferably from monocotyledonous or dicotyledonous plants, more preferably from dicotyledonous plants, or a sequence having substantial homology thereto and wherein said DNA sequence is capable in plants of influencing sensitivity to any member of the cytokinin hormone family, including derivatives based thereon, or any purine-related signalling compound of plant origin, including derivatives based thereon.
  • signalling compounds derived from plant, fungi, bacteria or other pathogens or environmental stimuli signalling through a G protein, wherein the DNA of this invention influences sensitivity to these compounds in plants is also claimed. Derivatives of the compounds described above would include both natural or synthetic varieties.
  • the invention relates to a gene having a nucleotide sequence either comprising the sequences shown in Fig. 1 or Fig. 2 or a substantially homologous sequence through degeneracy of the genetic code, including derivatives, mutants, or chimaera ⁇ or homologues capable of specific hybridization with the sequences shown in Fig. 1 or Fig. 2 and which still encode a G protein-coupled receptor homologue in plants.
  • substantially homologous DNA sequences may be 60% homologous, preferably 80% and most preferably around 90 to 95% homologous, or more, as compared to a reference sequence and substantially homologous amino acid sequences may preferably be 35%, more preferably 50%, most preferably more than 50% homologous as compared to a reference sequence.
  • Homology also includes a relationship wherein one or several subsequences of nucleotides or amino acids are missing, or subsequences with additional nucleotides or amino acids are interdispersed.
  • a GPCR homologue would typically be defined as any protein which has a predicted structure characteristic of the GPCR superfamily (see: Strader et al , Ann .Rev. Biochem, 63: 101-132 (1994)) and has significant amino acid sequence identity to GPCRs across all 7 putative transmembrane spanning regions or is a protein signalling through a G protein and bears a functional similarity with G protein-coupled receptors already known in vertebrates, invertebrates, arthropods, insects, nematodes, fungi, yeast, and viruses.
  • the degree of amino acid sequence identity may be calculated, for example, using a program such as "bestfit” (Smith and Waterman, Advances in Applied Ma thema tics , pp.482-489 (1981)) to find the best segment of similarity between any two sequences.
  • the alignment is based on maximising the score achieved using a matrix of amino acid similarities, such as that described by Schwarz and Dayhof ⁇ Atlas of Protein Sequence and Structure, Dayhof, M.O., pp. 353-358 (1979)).
  • the term "specific hybridization” is defined as the formation of hybrids between a targeting transgene sequence (e.g., a polynucleotide of the invention which may include substitutions, deletions, and/or additions) and a specific target DNA sequence (e.g., a GPCR), wherein a labelled targeting transgene sequence preferentially hybridizes to the target such that, for example, a single band corresponding to a restriction fragment of a gene can be identified on a Southern blot of DNA prepared from cells using said labelled targeting transgene sequence as a probe. It is evident that optimal hybridization conditions will vary depending upon the sequence composition and length(s), and the experimental method selected by the practioner.
  • a fragment of a DNA sequence as used by this invention is defined as any portion of the AtCGRl gene or a homologue thereof which influences sensitivity to cytokinins or to purine-related signalling compounds, including any synthetic derivatives of both or which can influence sensitivity to any other signalling coumpound derived from plant, fungal, bacterial or pathogen origin, including environmental stimuli which signal through a G protein. Discovering suitable fragments would certainly be within the skills of one in the art.
  • each of the 7 putative transmembrane spanning regions specifically, those regions of the GPCR involved in interacting with the G-alpha subunit of G proteins (in particular, cytoplasmic loops 2 and 3, including the amino acid residues in the transmembrane regions near to the cytoplasmic face) are possible AtGCRl fragment candidates for influencing sensitivity to the above- described compounds .
  • GPCR kinases GPCR kinases
  • a GPCR phosphatase reverses this process and then re-sensitizes the receptor.
  • AtGCRl has the characteristic Ser residues and a Thr residue in the C terminal cytoplasmic region and thus would make a good target (i.e. fragment) for manipulating sensitivity.
  • AtGCRl or homologues thereto affects (i) ligand binding; (ii) coupling to G proteins and (iii) sensitization/desensitization.
  • This invention also relates to the cDNA sequence of Fig. 2, wherein said cDNA sequence encodes for a GPCR homologue isolated from the family Cruciferae, or more specifically from the genus/species: Arabidopsis thaliana or any polypeptide having approximately 35%, preferably at least 50%, and most preferably more than 50% homology with the cDNA sequence of Fig. 2, said GPCR homologue signalling through a G protein in plants.
  • the GPCR homologue is capable of influencing sensitivity to cytokinins in plants.
  • the isolated or recombinant DNA is in the form of a cDNA clone and said cDNA clone encodes for a polypeptide which is capable of influencing the sensitivity of a subject plant to the cytokinin, benzyladenine .
  • It is also an aspect of the present invention to provide a genetic construct comprising, a nucleotide sequence encoding a G protein-coupled receptor homologue, expression signals which include both promoter and terminator sequences and other regulatory sequences of the 3' and 5' untranslated regions and which are operably linked to the coding DNA sequence so as to ensure the expression of the corresponding gene product in the respective host organism.
  • the regulatory sequence may be inducible by use of a chemical.
  • Suitable control sequences that are preferred within the scope of the invention are those comprising promoter and 5' and 3' untranslated regulatory sequences that are functional in plants.
  • the regulatory sequence may also be obtained from either a cytokinin- inducible gene, cytokinin-regulated gene or a pathogenesis -related protein gene. Regulatory sequences in general may, independently, be derived from any source, such as, for example, virus, plant or bacterial genes.
  • the promoters and regulatory sequences can be constitutive in nature or can be regulated in their patterns of expression. Such regulation may be temporal or spatial and include developmentally-regulated promoters, inducible promoters, tissue-preferential promoters or tissue-specific promoters. In particular, pith-specific promoters are desirable. Proteins may be optionally targeted to the vacuole or extracellularly using methods well known in the art.
  • chimaeric genetic constructs wherein the chimaeric construct may comprise, for example, constructs in which domains or amino acids involved in either ligand binding, interaction with G proteins or receptor sensitivity are altered so as to confer either different ligand-binding characteristics, the ability to signal to a different (heterologous) G protein or to alter sensitivity to regulation.
  • any promoter and any terminator capable of going about an induction of the expression of a coding DNA sequence may be used as a constituent of the gene sequence according to the invention.
  • the expression signal may promote continuous and stable expression of the gene.
  • expression signals originating from genes of plants or plant viruses are those of a cauliflower mosaic virus gene or of homologous DNA sequences that still have the characteristic properties of the mentioned expression signals.
  • bacterial expression signals especially the expression signals of the nopaline synthase genes (nos) or the opine synthase genes (ocs) from the Ti-plasmids of Agro-bacterium tu-Tiifaciens.
  • ubiquitin promoters for example, actin promoters, histone promoters and tubulin promoters.
  • Other suitable promoters are an amylase promoter (A-amylase promoter) and a ABA (abscisic acid) inducible promoter.
  • a promoter region may be used that is obtainable from the GPCR homologue sequence as described hereinbefore.
  • 35S and 19S expression signals of the CaMV genome or their homologues which can be isolated from the CaMV genome using molecular biological methods, as described for example in Maniatis et al . , and linked to the coding DNA sequence.
  • expression signals that comprise tissue-preferential of tissue-specific promoters.
  • a developmentally regulated promoter can also be used.
  • any promoter which is functional in the desired host plant can be used to direct the expression of an associated gene.
  • the plant G protein-coupled receptor homologue may be linked to the promoter region in either a sense or antisense orientation.
  • It is also an aspect of the invention to provide transformed host cells comprising recombinant DNA encoding a G protein-coupled receptor in operable linkage with expression signals including promoter and termination sequences which permit expression of said DNA in the host cell.
  • the invention further comprises a genetic construct comprising at least a part of a reverse G protein-coupled receptor nucleotide sequence, in operable linkage with plant or fungal expression signals including promoter and termination sequences capable of causing the reverse sequence to express antisense mRNA within a plant.
  • a genetic construct comprising at least a part of a reverse G protein-coupled receptor nucleotide sequence, in operable linkage with plant or fungal expression signals including promoter and termination sequences capable of causing the reverse sequence to express antisense mRNA within a plant.
  • the transformed host cells containing the antisense mRNA construct is also claimed in this invention. Therefore, antisense coding regions for the AtGCRl gene are also contemplated by this invention. Introducing the coding region of a gene in the reverse orientation to that found in nature can result in the down-regulation of the gene and hence the production of less or none of the gene product .
  • RNA transcribed from antisense DNA is capable of binding to, and destroying the function of, a sense RNA version of the sequence normally found in the cell thereby disrupting function. It is not crucial for antisense RNA solely to be transcribed at the time when the natural sense transcription product is being produced. Antisense RNA corresponding to some or all of the DNA encoding the G protein-coupled receptor may therefore be produced not only while the AtGCR gene or its equivalent is being expressed. Such antisense RNA may be expressed constitutively, under the control of any appropriate promoter .
  • Another possible means of reducing expression is for example the use of ribozy ⁇ ne technology as described in EP-A-321 201 or WO 89/05852.
  • a combination of antisense and ribozy e technology may also be used with the scope of the present invention for modifying cytokinin sensitivity.
  • antisense nucleic acid which includes a transcribable strand of DNA complimentary to at least part of the strand of DNA that is naturally transcribed in a gene encoding the isolated G protein- coupled receptor homologue in Arabidopsis or an equivalent protein in another member of the family Cruciferae .
  • Antisense expression of whole or part of a plant GPCR homologue would be expected to decrease the level of GPCR homologue and render the plant less sensitive to the natural ligand.
  • Sense over-expression of the entire GPCR homologue would elevate the level of the GPCR homologue, likely increasing the sensitivity to the ligand.
  • methods such as using a transgenic plasmid sequence, screening a library by testing for binding activity with AtGCRl or any other suitable method known in the art for isolating homologues to AtGCRl or compounds which bind to AtGCRl or prevent binding to the natural ligand are also claimed under this invention.
  • Standard techniques in recombinant DNA technology can be used as part of the method, such as hybridisation using cDNA probes, polymerase chain reaction using degenerate primers, and restriction fragment length polymorphisms (RFLP) .
  • a method of preparing a recombinant DNA encoding a plant GPCR homologue may include preparing a genomic or a cDNA gene library by customary methods known to those skilled in the art.
  • the basic methods of producing genomic or cDNA gene libraries are described in detail, for example, in Maniatis et al . , Molecular Cloning : A Labora tory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1982) , while information relating to the transfer and application of those methods to plant systems will be found, for example in Mohnen et al . , EMBO Journal , 4:1631-1635 (1985) . Genomic DNA and cDNA can be obtained in various ways.
  • Genomic DNA for example, can, using new methods, be extracted from suitable cells and purified.
  • the starting material used for the production of cDNA is generally mRNA, which can be isolated from selected cells or tissues. The isolated mRNA can then be used in reverse transcription as the matrix for the production of corresponding cDNA. Such techniques are well-known to those skilled in the art.
  • Extracted and purified DNA preparations may be cleaved into fragments for subsequent cloning.
  • Genomic DNA or cDNA to be cloned may be fragmented to a size suitable for insertion into a cloning vector either mechanical shearing or, preferably, by cleavage with suitable restriction enzymes.
  • Suitable cloning vectors which are already being used as a matter of routine for the production of genomic and/or cDNA gene libraries include, for example, phage vectors such as the ⁇ charon phages, or bacterial vectors, such as the E. coli plasmid pBR322.
  • suitable cloning vectors are known to those skilled in the art and may be obtained from commercial sources such as, for example, that contained in the "fast track" mRNA isolation kit obtainable from INVITROGEN or the ⁇ gtll cloning kit of Amersham. From gene libraries produced in this manner, suitable clones comprising the desired gene or parts thereof, can then be identified in a screening programme, for example with the aid of suitable oligonucleotide probes (probe molecule) , and then isolated. Various methods are available for identifying suitable clones, for example, differential colony hybridisation or plaque hybridisation. Immunological detection methods based on identification of the specific translation products may also be used.
  • a corresponding DNA sequence can be drawn up on the basis of that sequence information. On the basis of that information, it is thus possible to draw up all the nucleotide molecules that can be used as probe molecules for the identification and isolation of suitable clones by hybridising the probe molecules with genomic DNA or cDNA in one of the methods described above.
  • genomic DNA but preferably cDNA
  • a desired gene product in the present case a G protein-coupled receptor homologue, such as AtGCRl -- and then spliced into a suitable expression vector.
  • the resulting library can then be screened using suitable means, preferably using antibodies, and those clones selected which comprise the desired gene or at least part of that gene as an insert.
  • total DNA from the DNA library can be prepared and used as a template for a PCR reaction with primers representing low degeneracy portions of the desired amino acid sequence.
  • the primers used will generate PCR products that represent a significant portion of the nucleotide sequence.
  • the PCR products can be further probed to determine if they correspond to a portion of AtGCRl using a synthetic oligonucleotide probe corresponding to an amino acid fragment sequence.
  • the cDNA clones and PCR products prepared as described above or fragments thereof, may also be used as a hybridisation probe to identify further DNA sequences from a homologous or heterologous source organism encoding a similar G protein-coupled receptor homologue to AtGCRl , such as, for example, from fungi or a mono or dicotyledonous plant . They may also be used as a RFLP marker to determine, for example, the location of other G protein- coupled receptors or a closely linked receptor in the plant genome or for marker assisted breeding (EP-A- 0306139; WO 89/07647) .
  • TM domains of AtGCRl would be a good targeted region for designing PCR primers to isolate new GPCR homologues from Arabidopsis and homologues from other genera as well as from plants outside Cruciferae (also known as the family Brassicaceae) .
  • This approach ahs been used to PCR cine numerous novel GPCRs and GCPR homologues from other organisms (Parmentieret e al, Nature, 355:453-455 (1992) and Raming et al , Na ture, 361:353-356 (1993)).
  • the invention features vectors which contain recombinant or isolated DNA and which are preferably capable of directing expression of the protein encoded by the AtGCRl DNA in a vector-containing cell; and cells containing such vectors. Preferably, such cells are stably transfected with such isolated DNA.
  • Vectors for propagating a given sequence in a variety of host systems are well known and can readily be altered by one of skill in the art so that the vector will contain the G protein-coupled receptor homologue sequence and will be propagated in a desired host.
  • Such vectors include plasmids and viruses and hosts include eukaryotic organisms and cells, for example yeast, insect, plant, mouse or human cells, and prokaryotic organisms, for example E. coli and B . su tillus .
  • Cloning vectors generally carry an origin of replication, especially in origin replication as capable of functioning in E. coli , in AgroJbac erium or in both, and, in addition, specific genes that lead to phenotypic selection features in the transformed host cell, especially to resistance to antibiotics or to specific herbicides.
  • the transformed vectors can be selected on the basis of those phenotypic markers after transformation in a host cell.
  • the cloning vectors and the host cell transformed with these vectors are generally used to increase the number of copies of the constructs cloned therein. With an increased number of copies it is possible to isolate the vector carrying the chimeric gene construction and prepare it, for example, for insertion of the chimeric gene sequence into a plant cell.
  • shuttle vectors which can stably replicate not only in one, but in at least two different host organisms such as, for example, in E. coli and AgroJacteriu-n tumifaciens in the absence of a suitable selection marker.
  • Selectable phenotypic markers that may be used within the scope of this invention include, for example, resistance to ampicillin, tetracyclin, hygromycin, kanamycin, methotrexate, G418 and neomycin. But this, which is given by way of example, is not intended to limit the subject of the invention.
  • Preferred, however, is a binary vector system.
  • DNA in accordance with the invention (whether a promoter plus the AtGCRl gene product or antisense DNA to the AtGCRl gene) will be introduced into plant cells, by suitable means.
  • a plant cell comprising DNA in accordance with the invention as described above.
  • DNA is transformed into plant cells using a disarmed Ti-plasmid vector and carried by AgroJac eri m by procedures known in the art, such as EP-A-0116718 and EP-A-0270822.
  • the foreign DNA could be introduced directly into plant cells using an electrical discharge apparatus. This method is preferred where Agrobacterium is ineffective, for example where the recipient plant is monocotyledonous . Any other method that provides for the stable incorporation of the DNA within the nuclear DNA of any plant cell of any species would also be suitable. This includes species of plants which are not currently capable of genetic transformation.
  • the DNA in accordance with the invention may also contains a second gene (a "marker" gene) that enables a transformed plant containing the foreign DNA to be easily distinguished from other plants that do not contain the foreign DNA.
  • a marker gene examples include antibiotic resistance (Herrera-Estrella et al , 1983) , herbicide resistance (EP-A-0242246) and glucuronidase (GUS) expression (EP-A-0344029) .
  • Expression of the marker gene is preferably controlled by a second promoter which allows expression in cells other than for the hereinbefore described G protein-coupled receptor homologue, thus allowing selection of cells or tissue containing the marker at any stage of regeneration of the plant.
  • the preferred second promoter is derived from the gene which encodes the 35S subunit of Cauliflower Mosaic Virus (CaMV) coat protein. However, any other suitable second promoter could be used.
  • Another possible method of introducing genetic material into plant cells comprises, for example, bringing plant cells into contact with viruses or with Agrobacterium comprising the DNA to be introduced. This may be achieved by infecting sensitive plant cells or by co- cultivating protoplasts derived from plant cells.
  • cauliflower mosaic virus may be used as a vector for the insertion of the G protein-coupled receptor DNA sequence according to the invention into a plant.
  • Another method of inserting the G protein-coupled receptor DNA sequence into a cell makes use of the infection of the plant cell with Agrojbac eriu-m tumefaciens and/or Agrobacterium rhizogenes, which has previously been transformed with the gene construction.
  • the transgenic plant cells are then cultured under suitable culture conditions known to those skilled in the art, so that they form shoots and roots and whole plants are then formed.
  • a further possible method of transforming plant material comprises mixed infection using both Agrobacterium rhizogenes and transformed Agrojbacteriu-7. tumefaciens as described by Peder et al . , Molecular Genetics 202 388
  • the G protein-coupled receptor homologue DNA sequence according to the invention may also be transformed into suitable plant cells by means of, for example, the TI- plasmid of Agrobacterium tumefaciens or the RI -plasmid of Agrobac erium rhizogenes .
  • the Ti-plasmid or RI-plasmid is transferred to the plant in the course of infection by Agrojbac eriu-n and integrated in stable manner into the plant genome .
  • Any tDNA containing vector can be transferred into plant cells and permit selection of the transformed cells is suitable for use within the scope of this invention, such as, for example, a shuttle vector that comprises the G protein-coupled receptor DNA sequence (AtGCRl ) cloned in between the left border sequence and the right border sequence and that is capable of stable replication both in E. coli and Agro_bacteriu_ ⁇ ! tumefaciens .
  • a shuttle vector that comprises the G protein-coupled receptor DNA sequence (AtGCRl ) cloned in between the left border sequence and the right border sequence and that is capable of stable replication both in E. coli and Agro_bacteriu_ ⁇ ! tumefaciens .
  • AtGCRl G protein-coupled receptor DNA sequence
  • Possible methods for the direct transfer of genetic material into a plant cell comprise, for example, the treatment of protoplasts using procedures that likely modify the plasma membrane, for example, polyethylene glycol treatment, heat shock treatment or electroporation, or a combination of those procedures
  • Fig. 1 a fragment of a homologue of AtGCRl isolated from oilseed rape ⁇ Brassica napus- -BnGCRl) .
  • the genomic DNA sequence for this homologue is given in Fig. 10. It would also be with the abilities of one skilled in the art to use the TM regions to design PCR primers to isolate and clone other GPCR homologues from plants. For instance, this method was followed and a homologue was isolated from Brassica olesacea (i.e. broccoli) (BoGCRl) . This nucleotide sequence is represented in Fig. 15.
  • the present invention also comprises transgenic plant propagation material, selected from any of protoplasts, cells, calli, tissues, organs, seeds, embryos, ovules, zygotes, etc., and especially, whole and preferably phenotypically normal plants, that have been transformed by means of the processes described above and comprises the recombinant DNA according to the invention in expressible form, and of said transgenic plant material.
  • the process for production of transformed plant material thus essentially comprises: first isolating from a suitable source or synthesising by means of known processes a DNA sequence for a plant GPCR homologue as described herein; operably linking said DNA sequence in a 5' to a 3 ' direction to plant expression sequences as defined hereinbefore; transforming the construct of the above step into plant material by means of known processes in expressing it therein; screening of the plant material treated according to the third step for the presence of a DNA sequence to the G protein- coupled receptor described herein; and optionally, regenerating the plant material transformed according to the third step to a whole and preferably phenotypically normal plant and may include the desirable new trait or property.
  • Plants particularly desirable for use in this invention include, but are not limited to: vegetable crops; herbs; arable crops; pasture grass; pasture legumes, such as Medicago species; fruits or ornamental trees, such as apple, pear, plum, citrus fruit, and grape; forestry trees, biomass crop, such as willow or poplar; an oilseed crop, such as oilseed rape or sunflower; tobacco; cotton; sugar beet; and graminaceous monocots.
  • asexual or sexual progeny of transgenic plants includes by definition, according to the invention, all mutants and variants obtainable by means of known processes, such as, for example, cell fusion or mutant selection and which still exhibit the characteristic properties of the initial transformed plant, together with all crossing and fusion products of the transformed plant material.
  • the proliferation material of transgenic plants is defined relative to the invention as any plant material that may be propagated sexually in vivo or in vi tro .
  • Particularly preferred within the scope of the present invention are protoplasts, cells, calli, tissues, organs, seeds, embryos, egg cells, zygotes, together with any other propagating material obtained from transgenic plants .
  • a further aspect of the invention is the provision of an antibody raised against or at least a part of the amino acid sequence for the isolated G protein-coupled receptor of Figs 1 and 2.
  • Such an antibody is useful in screening a cDNA library in suitable vectors derived from plant tissue RNA.
  • a method for screening potential agonists or antagonists to the AtGCRl gene for use in designing agrochemicals which affect cytokinin-related responses.
  • Such a method would include expressing the AtGCRl gene in a heterologous cell, such as yeast or even mammalian cells, and then testing a range of compounds, such as known cytokinins and cytokinin derivatives, for its binding affinity (or lack of binding) to AtGCRl .
  • AtGCRl gene may affect sensitivity to cytokinins in planta by signalling through compounds other than G proteins .
  • Fig. 1 The genomic nucleotide sequence of AtGCRl aligned with the fragment of BnGCRl . Introns are indicated in lower case, dots indicate sequence identities and dashes indicate gaps introduced to maximise the alignment .
  • the line drawing indicates intron/exon organisation and relationship between AtGCRl
  • Fig. 2 Nucleotide and deduced amino acid sequence of AtGCRl cDNA. TM-spanning domains are indicated by solid lines above the amino acid sequence and the positions of introns within the coding region are indicated by inverted triangles . Primers are underlined and alternative polyadenylation sites are double underlined.
  • Fig. 3 Kyte-Doolittle hydrophilicity plot. Analysis of the amino acid sequence of the ORF of AtGCRl was performed using Peptide structure of EGCG(VMS) 8.0 using a window of 10 and results are plotted as a hydrophobicity index. Predicted TM helices are numbered 1-7. A similar result was obtained using a window of 7.
  • FIG. 4 Serpentine model of AtGCRl showing residues conserved in other GPCRs. This figure also depicts the amino acid sequence and the possible arrangement of ⁇ - helical regions, intracellular and extracellular loops and the N- , C-terminii of AtGCRl .
  • Fig. 5 represents a multiple sequence alignment between AtGCRl, CAR1 (from Dictyostrelium discoideum cAMP receptor) , CTRI (human calcitonin receptor) and CRF3 (rat corticotrophin releasing factor receptor) .
  • CAR1 from Dictyostrelium discoideum cAMP receptor
  • CTRI human calcitonin receptor
  • CRF3 rat corticotrophin releasing factor receptor
  • Fig. 6 Radial dendrogram showing relationship of AtGCRl with GPCRs. Sequences compared were: Family A, M64391
  • OLF-R P34969
  • Family B L2332, L2333, X72304, L25438, P35353 and X72305 (CRF-Rs) , L19475, X78936, M77184 and M74445 (PTH-Rs), L00587, P30988, X69920, M74420, L14617, L14618, L13040, L13041 and X70658 (CT- Rs)
  • CARs Family E, A54813, A46390, P34907, P35352 and P13773
  • Sequences of peptides indicated to be most similar to AtGCRl were aligned using CLUSTAL V and analysed using the PHYLIP suite of programs .
  • PROTDIST was used to compare sequences by the Dayhoff PAM algorithm
  • NEIGHBOR was used for neighbour- joining cluster analysis
  • radial phylogenetic trees were drawn using Treeview for Windows. Editing the sequence alignments, by deleting regions of gap introductions, yielded essentially the same tree (not presented) suggesting that the topology of the tree is robust.
  • Fig. 7 Northern blot. Poly A + RNA (9 ⁇ g) from Arabidopsis seedlings was probed with labelled AtGCRl cDNA.
  • Fig. 8 RT-PCR on Arabidopsis total RNA.
  • cDNA generated from poly A+ RNA isolated from light- (lane 1) and dark- (lane 2) grown 4 day seedlings. Amplimers used produced a 1 kb cDNA product.
  • Lane 3 is a positive control using the cDNA clone as template.
  • Using total RNA from whole plant (lane 4) leaves (lane 5) and stems (lane 6) from two-week-old plants.
  • Lane 7 is a minus template control.
  • stems (lane 8) leaves (lane9) and roots (lane 10) from seven-week-old plants.
  • Track m contains size markers indicated in base pairs (bp) . Amplimers used to roduce a 265 bp product from cDNA and a 392 bp product from genomic DNA traces of which are present in the total RNA.
  • Fig. 9 Southern blot. Arabidopsis DNA (10 ⁇ g/track) probed with AtGCRl cDNA. Lane 1, Ec ⁇ RI ; lane 2, BamHI . Fig. 10 represents the genomic nucleic acid sequence of the AtGCRl homologue, BnGCRl , isolated from Brassica napu ⁇ .
  • Fig. 11 details alignment of two EST sequences compared with that of the AtGCRl cDNA sequence.
  • the single long open reading frame is between bases 202-1180; nucleotides are numbered in relation to the sequence of AtGCRl .
  • Fig. 12 BA-inhibition of root growth. Seedlings germinated and grown five days on basal medium without additions and with a range of concentrations of BA. BARs indicate standard errors.
  • Fig. 13 BA inhibition of etiolation. Seedlings germinated and grown in the dark for five days on basal medium without additions and with a range of concentrations of BA. Bars indicate standard errors.
  • Fig. 14 Eight-week-old Arabidopsis plants.
  • the plant on left is a vector-only control. It has numerous flowering stems.
  • the plant on the right is an Anti 11, T4 having a single short primary flowering stem, several shorter secondary flowering stems and more extensive vegetative growth than the control plant.
  • Fig. 15 represents the genomic nucleic acid sequence of the AtGCRl homologue, (BoGCRl) , isolated from Brassica olesacea (broccoli) .
  • AtGCRl was not unique to Arabidopsis .
  • degenerate primers based on the open reading frame (ORF) were used to isolate a homologue ⁇ BnGCRl ) from Brassica napu ⁇ var .
  • Fido DNA Fig. 1 and Fig. 10.
  • the exons of AtGCRl and BnGCRl are 91% identical with 100% amino acid conservation over the region examined. The genes have similar intron/exon organization suggesting structural and functional conservation.
  • GPCRs The protein sequence of >700 GPCRs is known and all have seven stretches of 20-28 hydrophobic amino acids each capable of forming a TM ct- helix. Thus, GPCRs are thought to traverse the membrane seven times with associated extracellular and intracellular domains.
  • the proposed structure of AtGCRl is characteristic of GPCRs (Fig. 3) .
  • the amino acid sequence of AtGCRl has a number of residues that are conserved in GPCRs (Fig. 4).
  • the majority of GPCRs contain cysteines in the second and third extracellular loops that are thought to form a disulfide bridge. Mutation of these affects ligand binding and receptor expression.
  • AtGCRl has cysteines in the first and second extracellular loops that likely form a disulfide bridge.
  • the second extracellular loop of AtGCRl has a potential N-linked glycosylation site, consistent with many GPCRs.
  • TM2 of AtGCRl contains the motif LAXXD which is highly conserved in family A GPCRs.
  • the aspartate of this motif is one of the most highly conserved amino acids in GPCRs and is thought to be involved in transduction of agonist binding.
  • AtGCRl has an arginine conserved in virtually all GPCRs.
  • Other conserved residues include tryptophan in TM4 , the motif FXXP in TM5 and asparagine and tyrosine in TM7.
  • AtGCRl has multiple serines and threonmes in the C-terminus that may be sites of reversible phosphorylation and regulation by receptor kinases .
  • serine 303 in the Dicteos eli m cAMP receptor, CARl is phosphorylated during agonist -induction and this serine is conserved in AtGCRl .
  • the plant GPCR showed highest similarity to all members of family F, [Dicteosteliurn cAMP receptors (CAR1-4)], significant similarity to family B [corticotrophin releasing factor receptors (CRF- R) and calcitonin receptors (CT-R) ] and a number of serotonin (5HT7) and olfactory receptors of family A.
  • CAR1-4 family F
  • family B corticotrophin releasing factor receptors
  • C-R corticotrophin releasing factor receptors
  • C-R calcitonin receptors
  • 5HT7 serotonin
  • olfactory receptors of family A A score table is presented comparing AtGCRl with the highest scoring representatives from these families (Table 1) .
  • Multiple sequence alignment of AtGCRl against three GPCRs with which it shows highest similarity showed strong collinear sequence similarity and good alignment of all seven putative TM regions (Fig. 5) .
  • AtGCRl Alignment of AtGCRl with the 5HT7 receptor (P34969) also indicated good collinear alignment over the seven TM domains (not presented) .
  • Phylogenetic analysis indicated that A tGCRl may form the basis of a new family of GPCRs.
  • RNA blot analysis indicated low levels of the A tGCRl transcript (Fig. 7) .
  • RT-PCR revealed expression in whole, two-week-old plants and in root, stem and leaves of two-week and seven-week plants (Fig. 8) . It remains likely that there may be high level expression but within specific cells of each tissue.
  • the Arabidopsis G ⁇ - subunit gene GPA1 is expressed in a range of tissues during all stages of development of the plant.
  • AtGCRl is a single copy gene (Fig. 9) .
  • AtGCRl cDNA was therefore used to screen the Arabidopsis CIC library in pYAC4.
  • Two YAC clones hybridised to AtGCRl , one of which was anchored to the RFLP marker m291b which maps to chromosome 5 at 76.4cM.
  • the Dainty phenotype resembles the cytokinin- resistant mutant of Arabidopsis cyrl , located on chromosome 5, between 76.2 and 77.6cM.
  • the rationale for this was supported by the chemical similarities between cytokinins and cAMP, the ligand for the GPCRs to which A tGCRl shows the greatest similarity.
  • Anti 11, T3 seeds from a parent with a Dainty phenotype were plated on the cytokinin, benzyladenine (BA) .
  • Wild type Arabidopsis had roots 20 ⁇ 1.5mm long after five days' germination, which were reduced by 98% to 0.4 ⁇ 0.1mm on BA.
  • Arabidopsis carrying the binary vector had roots 21.3 ⁇ 1.6mm long reduced by 96% to 0.8 ⁇ 0.3mm on BA.
  • the Anti 11 seedlings had roots 15.5+1. lmm long which were, however, reduced by 54% to 7.1+0.3mm on BA. This suggested that antisense AtGCRl had reduced the sensitivity of the seedlings to BA.
  • AtGCRl is playing an important role in cytokinin signal transduction we would expect that a reduced sensitivity to cytokinin would be apparent in other tissues of antisense AtGCRl plants.
  • Cytokinins can overcome etiolation in Arabidopsis (Chory et al . , Plant Physiol . 104: 339-347 (1994)) and we demonstrated that BA was significantly less effective at reducing hypocotyl elongation in dark-grown antisense AtGCRl seedlings compared with the control. This reduction in cytokinin sensitivity in shoot tissues is further supported by the pronounced apical dominance of Anti 11, T4 plants (Fig. 14). Thus, AtGCRl influences cytokinin sensitivity in both roots and shoots.
  • the T4 generation of the Anti 11 plants displayed substantially delayed flowering and consequently an extended phase of vegetative growth. By suppressing flowering by prolonging vegetative growth would increase the yield of vegetables, particularly those that are prone to bolting (e.g. cabbage, lettuce, onion and other Allium sp, and sugar beet) .
  • AtGCRl To determine the relationship of AtGCRl to cyrl, we amplified AtGCRl from cyrl seedling DNA.
  • the amino acid sequence of the ORF from cyrl and CYR1 were identical and there were no differences at intron/exon splice sites. AtGCRl does not therefore appear to be involved in the cyrl mutation.
  • CYR1 likely encodes a closely linked and possibly downstream component for the AtGCRl GPCR.
  • Table 1 Amino acid sequence similarity and identity values between AtGCRl and GPCRs
  • the deduced amino acid sequence of AtGCRl was compared, using the GAP programme of EGCG 8.0, against the Rattus Norvegi cus corticotropin releasing factor receptor 1 (CRF-R) (P35353) (24), human calcitonin receptor (CT-R) (P30988) (25) , Dictyostelium discoideum cAMP receptor (CARD (P13773) (26) and the human 5-hydroxytryptamine receptor 7 (5HT7) ( P34969) 16 .
  • CRF-R Rattus Norvegi cus corticotropin releasing factor receptor 1
  • CCF-R human calcitonin receptor
  • CARD Dictyostelium discoideum cAMP receptor
  • 5HT7 human 5-hydroxytryptamine receptor 7
  • Root lengths were measured four days post -germination of Arabidopsis seedlings (mean of >20) . P values were determined by unpaired two-tailed t test. (-); not significant, (***); extremely significant.
  • BA benzyladenine (6 ⁇ M) ;
  • IAA indole-3 -acetic acid (10 ⁇ M) ;
  • ACC 1-aminocyclopropane-l-carboxylic acid (10 ⁇ M) .
  • Arabidopsis thaliana (Colombia) was germinated on tissue culture plates in Murashige and Skoog Basal Medium (Sigma) with 1% agarose and 1.5% sucrose, and maintained in containment rooms. Plants for seed production were grown under transgenic greenhouse conditions .
  • the flowering parts of five-week-old plants were vacuum infiltrated 31 with Agrobacterium tumefaciens (GV3101) carrying the plant binary transformation vector, pLARS120.
  • the AtGCRl cDNA sequence was cloned into the vector in the antisense orientation, under the control of a 35S cauliflower mosaic virus promoter cassette.
  • seeds were harvested, transformants selected on plates with kanamycin (50 ⁇ g/ml) and grown to seed. The selection was repeated to identify those with a segregation ratio of 3 resistant to 1 sensitive plant (one copy of the T- DNA inserted) .
  • Seeds of the mutant cyrl were obtained from the Arabidopsis Biological Resource Center, Ohio USA. These were germinated and the homozygous plants distinguished from the heterozygotes and wild type by virtue of their failure to thrive. DNA was prepared after seven days' germination on tissue culture plates.
  • PolyA * RNA was isolated from seven-day-old etiolated Arabidopsis by phenol/chloroform extraction and oligo dT cellulose (Pharmacia) chromatography.
  • RACE Rapid amplification of cDNA ends

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Procédé de modification des voies de transduction de signal de protéine G dans des plantes, ce qui permet d'influer sur la croissance de la plante, son développement et ses réactions à des molécules endogènes de signalisation, à des signaux émis par le milieu, à des parasites et à des agents pathogènes. On a découvert, isolé et cloné un récepteur couplé à la protéine G dans Arabidopsis thaliana, Brassica napus et Brassica oleracea. On a spécifiquement isolé et purifié la séquence d'ADNc codant la longueur totale du récepteur d'Arabidopsis thaliana, ainsi que sa séquence d'acides aminés. On pense que ce récepteur isolé couplé à la protéine G exerce une influence sur la sensibilité des plantes aux cytokinines.
EP97929402A 1996-06-28 1997-06-30 Transduction de signal de proteine g dans des plantes Withdrawn EP0918862A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9613617.1A GB9613617D0 (en) 1996-06-28 1996-06-28 G Protein signal transduction in plants
GB9613617 1996-06-28
GBGB9706118.8A GB9706118D0 (en) 1997-03-25 1997-03-25 G protein signal transduction in plants
GB9706118 1997-03-25
PCT/GB1997/001766 WO1998000545A2 (fr) 1996-06-28 1997-06-30 Transduction de signal de proteine g dans des plantes

Publications (1)

Publication Number Publication Date
EP0918862A2 true EP0918862A2 (fr) 1999-06-02

Family

ID=26309589

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97929402A Withdrawn EP0918862A2 (fr) 1996-06-28 1997-06-30 Transduction de signal de proteine g dans des plantes

Country Status (5)

Country Link
EP (1) EP0918862A2 (fr)
JP (1) JP2000513937A (fr)
AU (1) AU3351997A (fr)
CA (1) CA2258694A1 (fr)
WO (1) WO1998000545A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985584A (en) * 1997-02-19 1999-11-16 American Cyanamid Company Method to identify plant proteins that function in G protein coupled systems and compositions therefor
EP1003892A2 (fr) * 1997-07-30 2000-05-31 Instituut voor Agrobiologisch en Bodemvruchtbaarheidsonderzoek ( AB-DLO) Inhibition de l'action non desiree d'hormones dans des plantes
AU781721B2 (en) * 1999-04-16 2005-06-09 Pioneer Hi-Bred International, Inc. Regulated expression of genes in plant seeds
EP1206559A2 (fr) * 1999-08-26 2002-05-22 Plant Research International B.V. Inhibition conditionnelle de multiplication vegetative
AU2001255250A1 (en) * 2000-04-07 2001-10-23 Basf Plant Science Gmbh Cell cycle stress-related proteins and methods of use in plants
CA2449553A1 (fr) * 2001-06-05 2002-12-19 Arena Pharmaceuticals, Inc. Versions non endogenes consecutivement activees de recepteur couple a une proteine g de vegetal: gcr1
WO2006138606A2 (fr) 2005-06-17 2006-12-28 Arborgen, Llc Genes de signalisation de cellules et procedes apparentes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9800545A3 *

Also Published As

Publication number Publication date
AU3351997A (en) 1998-01-21
WO1998000545A2 (fr) 1998-01-08
WO1998000545A3 (fr) 1998-03-12
JP2000513937A (ja) 2000-10-24
CA2258694A1 (fr) 1998-01-08

Similar Documents

Publication Publication Date Title
EP1681349B1 (fr) Régulation génétique de la croissance et du développement végétaux
AU717860B2 (en) Flowering genes
US6307126B1 (en) Nucleic acid encoding GAI gene of Arabidopsis thaliana
US7256326B2 (en) Genetic engineering salt tolerance in crop plants
AU2008286583B2 (en) A plant height regulatory gene and uses thereof
CA2323756C (fr) Genie genetique de l'halotolerance dans les plantes cultivees
CA2337093A1 (fr) Proteine kinase du type recepteur (rkn), technique d'utilisation de la rkn pour renforcer la croissance de plantes et accroitre leur rendement
EP0918862A2 (fr) Transduction de signal de proteine g dans des plantes
US5859338A (en) Plant clavata1 nucleic acids, transformed plants, and proteins
WO1999000501A1 (fr) Matieres et procedes relatifs a une proteine regulatrice vegetale
AU734895B2 (en) Gene for floral regulation and methods for controlling of flowering
US20030093835A1 (en) Chimeric genes controlling flowering
Okamoto et al. Photoresponses of transgenic Arabidopsis overexpressing the fern Adiantum capillus-veneris PHY1
Bradley Flowering genes
MXPA00001449A (en) Genetic control of plant growth and development

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990107

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010102